Exhibit 99.1

Verisk Analytics, Inc., Reports Fourth-Quarter and Fiscal-Year

2011 Financial Results

Delivers 19.9% Revenue Growth and 28.2% Diluted Adjusted EPS Growth in

Fourth Quarter

JERSEY CITY, N.J., February 28, 2012 — Verisk Analytics, Inc. (Nasdaq:VRSK), a leading source of information about risk, today announced results for the fourth quarter and fiscal year ended December 31, 2011:

Financial Highlights

See Tables 4 and 5 for a reconciliation of non-GAAP financial measures to the relevant GAAP measures.

Frank J. Coyne, chairman and chief executive officer, stated, “Verisk continued to deliver double-digit growth in revenue, EBITDA, and earnings per share. Within Decision Analytics, strong contributions to growth came from both solutions for our core property and casualty insurance customers and newer verticals such as healthcare, including our acquisitions of Bloodhound Technologies and Health Risk Partners. In healthcare, we are well positioned to deliver a comprehensive suite of solutions to our customers, and that continues to be reflected in our performance in the most recent quarter.”

“Risk Assessment continued its steady growth based on our long-standing, mission-critical solutions for the insurance industry and our insurance-facing solutions in Decision Analytics also continued strong organic growth of about 15%. We continue to see traction in cross sell and continue to work to create the optimal framework for increasing penetration of our services, including the creation of the Verisk Underwriting Solutions division.”

“The mortgage environment remains uncertain today as reflected in both the continued decline in originations and challenges faced by mortgage insurers, although our business has outperformed the underlying macro environment. We will maximize opportunities based on today’s environment and execute a strategy that will diversify and continue to enhance our business.”

“Our focus on disciplined capital management, both in our acquisition program and in share buybacks, delivered value. We expect to continue our approach to capital management in 2012, and remain focused on acquisitions as attractive opportunities to add to our business, when acquired at appropriate prices,” concluded Coyne.

Summary of Results for Fourth-Quarter and Fiscal-Year 2011

Table 1

Revenue

Revenue grew 19.9% for the quarter ended December 31, 2011 and 17.0% for fiscal-year 2011. Excluding the effect of recent acquisitions (Crowe Paradis, 3E, Bloodhound Technologies, and Health Risk Partners) — revenue grew 7.6% both in the fourth quarter and for fiscal-year 2011. Overall revenue growth was the result of continued double-digit growth in Decision Analytics and single-digit growth in Risk Assessment. For fourth-quarter and fiscal–year 2011, Decision Analytics revenue represented approximately 60% and 58% of total revenue, respectively.

2

Table 2A

Within the Decision Analytics segment, revenue grew 34.0% for fourth-quarter 2011, and organic growth was 11.0%. Growth in the quarter was driven by the continued strength in insurance vertical solutions and healthcare solutions. The mortgage market remained challenged, impacting the growth of revenue from solutions facing that market.

Within insurance vertical solutions, revenue growth was 19.5% (including the December 2010 acquisition of Crowe Paradis) and 14.6% organic growth for the fourth quarter of 2011. For the fiscal year, revenue from insurance solutions grew 21.0% and 14.6% organically. Our loss quantification solutions grew 27% in the quarter, contributing to the organic insurance vertical growth rate, as a result of new customer contracts, new solutions such as our contents tools, and higher assignment volumes related to storm activity. Catastrophe modeling solutions continued double-digit growth. Our insurance fraud claims solutions also continued good revenue growth.

In the mortgage and financial services vertical, revenue declined 7.2% in the fourth-quarter and 1.9% for fiscal-year 2011, reflecting the weak macro environment for originations and the stabilizing to declining number of loans that are delinquent, defaulted, or in foreclosure. Based on those trends, revenue from both underwriting and forensic solutions declined in the quarter and fiscal year because new sales were not sufficient to offset the challenged mortgage environment.

In the healthcare vertical solutions, revenue grew 170.2% in the fourth-quarter and 78.9% for fiscal- year 2011. Total revenue growth included the acquisitions of Bloodhound Technologies and Health Risk Partners. Organic growth was 37.3% in the fourth quarter and 19.8% for fiscal 2011, reflecting continued customer implementations and new customer sales.

In the specialized markets category, revenue grew 134.0% in the fourth-quarter and 181.3% for fiscal-year 2011. Total revenue growth included the acquisition of 3E in December 2010. Organic revenue declined 1.6% in the fourth quarter as a result of the cycling to the full quarterly value of a government contract for weather analytics that began in 2010 and governmental budgetary delays. Organic revenue in this category grew 12.4% for fiscal 2011.

Table 2B

Within the Risk Assessment segment, revenue grew 3.9% for the fourth quarter, driven by revenue growth of 4.9% in industry-standard insurance programs resulting from growth in 2011 invoices effective from January 1. Total revenue growth for the Risk Assessment segment in fiscal-year 2011 was also 3.9%.

3

Property-specific rating and underwriting information revenue grew 0.5% for fourth-quarter 2011, as lower transactional volumes with certain customers were offset by increased use of property appraisal tools. Statistical agency and data services revenue grew 10.4% in the fourth quarter. Actuarial services revenue declined 0.2% in the quarter.

Cost of Revenue

Cost of revenue increased 20.5% in fourth-quarter 2011 and 6.1% excluding acquisitions. For fiscal year 2011, cost of revenue increased 15.2% and 5.1% excluding acquisitions. The increase relates primarily to the effect of annual compensation increases and increased headcount related to the growth of our business. Excluding recent acquisitions, cost of revenue increased 3.2% for Risk Assessment and 8.0% for Decision Analytics in the fourth quarter. For fiscal-year 2011, excluding recent acquisitions, cost of revenue decreased 0.5% for Risk Assessment and increased 9.2% for Decision Analytics.

Selling, General, and Administrative

Selling, general, and administrative expense, or SG&A, increased 16.8% in fourth-quarter 2011 and 2.7% excluding recent acquisitions. SG&A grew 4.8% for Risk Assessment in the fourth quarter. SG&A grew 26.3% for Decision Analytics and 0.8% excluding recent acquisitions in the fourth quarter.

For fiscal-year 2011, SG&A grew 25.9% and 7.0% excluding recent acquisitions. SG&A grew 5.7% for Risk Assessment in 2011. SG&A grew 44.1% for Decision Analytics and 8.2% excluding recent acquisitions in 2011.

EBITDA

For fourth-quarter 2011, consolidated EBITDA grew 20.5% to $158.4 million, with a consolidated EBITDA margin of 45.0%. For fiscal-year 2011, EBITDA grew 16.3% to $592.0 million, with a consolidated margin of 44.4%. The recent acquisitions affected margins negatively by 1.6% in the fourth quarter and 1.7% for the full-year 2011.

Table 3

Risk Assessment segment EBITDA grew 4.0% in the fourth quarter and 6.6% in fiscal 2011. Decision Analytics segment EBITDA grew 39.4% in the fourth quarter and 27.1% for fiscal 2011 versus the previous year, as shown in Table 3.

The fourth-quarter 2011 EBITDA margin in Risk Assessment increased to 51.4% from 51.3% in fourth-quarter 2010. The fiscal-year 2011 EBITDA margin for Risk Assessment increased to 50.8% from 49.5% in 2010, as salary and related costs rose at a slower rate than revenue, including the 0.5% margin benefit due to a decline in pension expense.

4

The fourth-quarter 2011 EBITDA margin for Decision Analytics increased to 40.7% from 39.1% in fourth-quarter 2010. The fiscal-year 2011 EBITDA margin for Decision Analytics declined to 39.8% versus 40.4%, as fiscal-year 2011 margins were negatively affected by 2.4% by the recent acquisitions of Crowe Paradis, 3E, Bloodhound, and HRP, which grew EBITDA but reduced margin.

Net Income and Adjusted Net Income

Net income increased 21.9% in fourth-quarter 2011 and 16.6% for fiscal-year 2011, driven by growth in the business, which was partially offset by increased borrowing costs associated with higher debt levels due to acquisitions and share buybacks. Adjusted net income grew 22.2% for fourth-quarter 2011 and 16.3% for fiscal-year 2011. The table below sets forth a reconciliation of net income to adjusted net income and adjusted EPS based on historical results:

Table 4

Net Cash Provided by Operating Activities and Capital Expenditures

Net cash provided by operating activities was $375.7 million and increased $39.7 million, or 11.8%, for the fiscal year ended December 31, 2011, compared with the same period in 2010. This growth was the result of a $70.5 million increase caused by the improved profitability of the business, partially offset by a $23.0 million decrease in working capital and an increase in taxes paid of $8.3 million, net of option benefits.

Capital expenditures were $68.4 million in the fiscal year ended December 31, 2011 — an increase of $27.4 million over the same period in 2010 due to periodic upgrades to our central technology platforms and related long-term leased software as discussed in previous quarters, as well as capital expenditures for our 2011 acquisitions. Capital expenditures were 5.1% of revenue for 2011. Net cash provided by operating activities less capital expenditures represented approximately 52% of EBITDA in 2011.

Share Repurchases and Senior Note Issuance

The company continued to balance its internal investment and acquisition initiatives with share repurchases. In fourth-quarter 2011, the company repurchased shares for a total cost of $40.6 million at an average price of $36.54. For fiscal-year 2011, the company repurchased shares for a total cost of $380.7 million at an average price of $33.61. At December 31, 2011, the company had $6.8 million remaining under its share repurchase authorization. On January 11, 2012, the company announced the authorization of an additional $300 million for share repurchases, which will be added to the 2011 balance and available for repurchases.

5

On December 8, 2011, the company issued $250 million of 4.875% senior notes and used $145 million of the proceeds to repay its revolving credit facility. Repayment of all amounts outstanding leaves $725 million of committed and unused availability under the revolver.

Conference Call

The company’s management team will host a live audio webcast on Wednesday, February 29, 2012, at 8:30 a.m. Eastern time (5:30 a.m. Pacific time) to discuss the financial results and business highlights. All interested parties are invited to listen to the live event via webcast on the Verisk investor website at http://investor.verisk.com. The discussion is also available through dial-in number 1-877-755-3792 for U.S./Canada participants or 706-758-8912 for international participants.

A replay of the webcast will be available on the Verisk investor website for 30 days and also through the conference call number 1-855-859-2056 for U.S./Canada participants or 404-537-3406 for international participants using Conference ID #44914444.

About Verisk Analytics

Verisk Analytics (Nasdaq:VRSK) is a leading provider of information about risk to professionals in insurance, healthcare, mortgage, government, supply chain, and risk management. Using advanced technologies to collect and analyze billions of records, Verisk Analytics draws on vast industry expertise and unique proprietary data sets to provide predictive analytics and decision-support solutions in fraud prevention, actuarial science, insurance coverages, fire protection, catastrophe and weather risk, data management, and many other fields. In the United States and around the world, Verisk Analytics helps customers protect people, property, and financial assets. For more information, visit www.verisk.com.

Forward-Looking Statements

This release contains forward-looking statements. These statements relate to future events or to future financial performance and involve known and unknown risks, uncertainties, and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance, or achievements expressed or implied by these forward-looking statements. In some cases, you can identify forward-looking statements by the use of words such as “may,” “could,” “expect,” “intend,” “plan,” “target,” “seek,” “anticipate,” “believe,” “estimate,” “predict,” “potential,” or “continue” or the negative of these terms or other comparable terminology. You should not place undue reliance on forward-looking statements because they involve known and unknown risks, uncertainties, and other factors that are, in some cases, beyond our control and that could materially affect actual results, levels of activity, performance, or achievements.

Other factors that could materially affect actual results, levels of activity, performance, or achievements can be found in Verisk’s quarterly reports on Form 10-Q, annual reports on Form 10-K, and current reports on Form 8-K filed with the Securities and Exchange Commission. If any of these risks or uncertainties materialize, or if our underlying assumptions prove to be incorrect, actual results may vary significantly from what we projected. Any forward-looking statement in this release reflects our current views with respect to future events and is subject to these and other risks, uncertainties, and assumptions relating to our operations, results of operations, growth strategy, and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, whether as a result of new information, future events, or otherwise.

6

Notes Regarding the Use of Non-GAAP Financial Measures

The company has provided certain non-GAAP financial information as supplemental information regarding its operating results. These measures are not in accordance with, or an alternative for, U.S. GAAP and may be different from non-GAAP measures reported by other companies. The company believes that its presentation of non-GAAP measures, such as EBITDA, EBITDA margin, adjusted net income, and adjusted EPS, provides useful information to management and investors regarding certain financial and business trends relating to its financial condition and results of operations. In addition, the company’s management uses these measures for reviewing the financial results of the company and for budgeting and planning purposes.

EBITDA

Table 5 below sets forth a reconciliation of net income to EBITDA based on our historical results:

Table 5

EBITDA is a financial measure that management uses to evaluate the performance of our segments. The company defines “EBITDA” as net income before investment and other income, realized (gain)/loss on securities, interest expense, income taxes, and depreciation and amortization of fixed and intangible assets. Beginning in 2011, our EBITDA includes acquisition-related liabilities adjustment for all periods.

Although EBITDA is frequently used by securities analysts, lenders, and others in their evaluation of companies, EBITDA has limitations as an analytical tool and should not be considered in isolation or as a substitute for an analysis of our statement of cash flow reported under U.S. GAAP. Management uses EBITDA in conjunction with traditional U.S. GAAP operating performance measures as part of its overall assessment of company performance. Some of these limitations are as follows:

7

Attached Financial Statements

Please refer to the full Form 10-K filing for the complete financial statements and related notes that are an integral part of the financial statements.

8

VERISK ANALYTICS, INC.

CONSOLIDATED BALANCE SHEETS

As of December 31, 2011 and 2010

Please refer to the full Form 10-K filing for the complete financial statements and related notes that are an integral part of the financial statements

9

VERISK ANALYTICS, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS

For the Quarters (Unaudited) and Years Ended December 31, 2011 and 2010

Please refer to the full Form 10-K filing for the complete financial statements and related notes that are an integral part of the financial statements

10

VERISK ANALYTICS, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

For the Years Ended December 31, 2011 and 2010

Please refer to the full Form 10-K filing for the complete financial statements and related notes that are an integral part of the financial statements

11

VERISK ANALYTICS, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS (continued)

For the Years Ended December 31, 2011 and 2010

Please refer to the full Form 10-K filing for the complete financial statements and related notes that are an integral part of the financial statements

12